Daryl Wiesen, a partner in Goodwin Procter’s IP Litigation Group, focuses his practice on patent litigation and advising clients in patent portfolio development. He has more than 15 years’ experience advising clients and participating in all phases of patent litigation, from initial counseling up through trial and appeal. Mr. Wiesen has developed an expertise in pharmaceutical patent litigation under the Hatch-Waxman Act, representing both plaintiffs and defendants. He also has experience in other technologies, including biotechnology and medical devices. He represents universities in patent and licensing disputes concerning technology discovered at the universities and then out-licensed to companies for further development.

Mr. Wiesen has been named a “Life Sciences Star” in the IP practice area by Euromoney’s LMG Life Sciences Guide. He has also been honored with the firm’s Robert B. Fraser Pro Bono Award tor his substantial pro bono work, including helping to obtain the freedom of a wrongfully convicted death row inmate in Ohio.